Abstract Objective Preferences of health professionals’ for human papilloma virus vaccines was measured by monetary value through willingness to pay (WTP) approach that could help policy makers set priorities among alternative cervical cancer prevention methods in poor countries. The objective of this study was to assess the female health professionals’ willingness to accept and pay, and associated factors for human papilloma virus vaccination at College of Medicine and Health Sciences, University of Gondar, Northwest Ethiopia. Results The majority (85.97%) of health professionals’ were willing to pay for Human papilloma virus vaccine. On the average, the respondents were willing to pay 231.34 ETB (US$8.50) per human papilloma virus vaccina...
Abstract. A cross-sectional survey was conducted to evaluate acceptability, know-ledge, and attitude...
Background: It has been well established that the human papillomavirus (HPV) plays a central role in...
Background The Human Papillomavirus (HPV) vaccine has offered a great promise to reduce the cervical...
IntroductionCervical cancer is a major public health problem in developing countries like Ethiopia. ...
Amount of money female health professionals were willingness to pay for cervical cancer screening se...
Background. Cervical cancer is Ethiopia’s second biggest cause of cancer-related death among women. ...
Abstract Background Cervical cancer is one of the most common cancers in women. Evidences show that,...
Cervical cancer is a preventable public health problem. The two new human papillomavirus (HPV) vacci...
BACKGROUND: Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing du...
Background: Cervical cancer, a leading cause of cancer deaths in women in developing countries can b...
papillomavirus (HPV) vaccine for the preven-tion of cervical cancer and its precursors offers the po...
Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The availability o...
Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The availability o...
Bach Xuan Tran,1,2 Phung Tat Quoc Than,3 Tien Thuy Ngoc Doan,1 Huong Lan Thi Nguyen,4 Hue Thi Mai,1 ...
Includes bibliographical references (pages 99-112)Cervical cancer is the leading cause of cancer-rel...
Abstract. A cross-sectional survey was conducted to evaluate acceptability, know-ledge, and attitude...
Background: It has been well established that the human papillomavirus (HPV) plays a central role in...
Background The Human Papillomavirus (HPV) vaccine has offered a great promise to reduce the cervical...
IntroductionCervical cancer is a major public health problem in developing countries like Ethiopia. ...
Amount of money female health professionals were willingness to pay for cervical cancer screening se...
Background. Cervical cancer is Ethiopia’s second biggest cause of cancer-related death among women. ...
Abstract Background Cervical cancer is one of the most common cancers in women. Evidences show that,...
Cervical cancer is a preventable public health problem. The two new human papillomavirus (HPV) vacci...
BACKGROUND: Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing du...
Background: Cervical cancer, a leading cause of cancer deaths in women in developing countries can b...
papillomavirus (HPV) vaccine for the preven-tion of cervical cancer and its precursors offers the po...
Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The availability o...
Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The availability o...
Bach Xuan Tran,1,2 Phung Tat Quoc Than,3 Tien Thuy Ngoc Doan,1 Huong Lan Thi Nguyen,4 Hue Thi Mai,1 ...
Includes bibliographical references (pages 99-112)Cervical cancer is the leading cause of cancer-rel...
Abstract. A cross-sectional survey was conducted to evaluate acceptability, know-ledge, and attitude...
Background: It has been well established that the human papillomavirus (HPV) plays a central role in...
Background The Human Papillomavirus (HPV) vaccine has offered a great promise to reduce the cervical...